Loading...
XSTO
ARCOMA
Market cap11mUSD
Dec 04, Last price  
7.30SEK
1D
2.53%
1Q
-18.89%
Jan 2017
93.63%
IPO
-37.45%
Name

Arcoma AB

Chart & Performance

D1W1MN
XSTO:ARCOMA chart
P/E
9.34
P/S
0.67
EPS
0.78
Div Yield, %
—
Shrs. gr., 5y
0.84%
Rev. gr., 5y
3.24%
Revenues
157m
-3.81%
147,661,334101,312,157130,434,000123,285,000102,081,00091,848,000119,470,000133,672,000117,417,000117,130,000125,046,000163,015,000156,807,000
Net income
11m
+336.00%
-3,226,662-11,624,161914,000-6,449,000-11,646,000-9,820,000-1,586,0006,610,0001,365,000-7,473,0001,902,0002,564,00011,179,000
CFO
19m
-1.64%
-10,267,844-11,822,783-828,000-4,948,000-4,666,000-8,910,00045,00011,100,0006,846,000-1,932,000-179,00019,160,00018,845,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.
URL
https://www.arcoma.se/
IPO date
Nov 14, 2014
Employees
32
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT